FDA Accepts for Priority Review the Supplemental Biologics License Application for Merck’s VAXNEUVANCE (Pneumococcal 15-valent Conjugate Vaccine) for Use in Infants and Children Read more
Premas Biotech and Oravax Medical to Test Their Triple Antigen Oral Vaccine Candidate Against Omicron Variant of Concern Read more
Astellas and Dyno Therapeutics Announce Research Collaboration to Develop Next-Generation AAV Gene Therapy Vectors for Skeletal and Cardiac Muscle Read more
AbbVie Submits Application for Risankizumab (SKYRIZI) in Moderate to Severe Crohn’s Disease to EMA Read more
Lynparza granted Priority Review in the US for BRCA-mutated HER2-negative high-risk early breast cancer Read more
Chiesi and UCB enter global license agreement for zampilimab a novel monoclonal antibody for fibrotic lung diseases Read more
Bone Therapeutics and Link Health sign a non-binding term sheet for the global rights of ALLOB Read more
FDA Actively Working to Investigate, Address Potential Impacts of Omicron Variant; Urges Vaccination and Boosters Read more
First Wave BioPharma Announces Independent Data Monitoring Committee Provides Positive Interim Safety Assessment for Part 2 COVID-19 RESERVOIR Clinical Trial of Niclosamide for the Treatment of Gastrointestinal Infections Read more